Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy
- 1 January 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 347 (8994) , 94-95
- https://doi.org/10.1016/s0140-6736(96)90213-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathyThe Lancet, 1995
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994
- Mistyping ACE heterozygotes.Genome Research, 1993
- Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac deathThe Lancet, 1993
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)Nucleic Acids Research, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Association between blood pressure and the rate of decline in renal function with ageKidney International, 1984